VWA
IDXX icon

Valued Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Valued Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8K Buy
32
+4
+14% +$2.24K 0.01% 225
2026
Q1 		$15.7K Buy
28
+1
+4% +$641 0.01% 213
2025
Q4 		$18.3K Buy
27
+1
+4% +$681 0.01% 168
2025
Q3 		$16.6K Hold
26
– – 0.01% 171
2025
Q2 		$13.9K Hold
26
– – 0.01% 183
2025
Q1 		$10.9K Hold
26
– – 0.01% 213
2024
Q4 		$10.8K Sell
26
-2
-7% -$877 0.01% 222
2024
Q3 		$14.1K Hold
28
– – 0.01% 185
2024
Q2 		$13.6K Buy
28
+3
+12% +$1.51K 0.01% 169
2024
Q1 		$13.5K Buy
25
+4
+19% +$2.19K 0.01% 155
2023
Q4 		$9.18K Buy
+21
New +$9.86K 0.01% 130

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Valued Wealth Advisors's IDXX Position: Q2 2026 in Review

Valued Wealth Advisors increased its Idexx Laboratories (IDXX) stake by 14% in Q2 2026, buying an estimated $2.24K and bringing the position to 32 shares worth $16.8K. The position accounts for 0.01% of the portfolio, ranked #225.

Valued Wealth Advisors first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $18.3K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Valued Wealth Advisors held 32 shares of Idexx Laboratories worth $16.8K as of Q2 2026.
  • Valued Wealth Advisors bought 4 Idexx Laboratories shares in Q2 2026, an estimated $2.24K.
  • Idexx Laboratories made up 0.01% of Valued Wealth Advisors's portfolio in Q2 2026, its #225 holding.
  • Valued Wealth Advisors first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
  • Valued Wealth Advisors's Idexx Laboratories position peaked at $18.3K in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Valued Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.